- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Here are the activist investor's next potential targets.
Plus more from the biotechnology world on Wednesday, June 7.
Sage Therapeutics, Incyte and Shire were among the biotech movers in premarket trading on Thursday.